The differentiation of bone marrow mesenchymal stem cells into chondrocyte-like cells on poly-L-lactic acid (PLLA) scaffolds.

While intervertebral disc (IVD) degeneration is associated with the majority of cases of low back pain, current treatments are symptomatic rather than curative. Tissue engineering offers a treatment that both cures the problem of disc degeneration and restores normal disc function. One of the major problems for any tissue engineering strategy, however, is ensuring that both the cells and matrices used are suitable for the target tissue. In this study, we have developed and studied a potential system for tissue engineering of the nucleus pulposus (NP) of the severely degenerate IVD. While cells from degenerate discs are not suitable for tissue engineering, bone-marrow-derived mesenchymal stem cells, which are capable of differentiating into chondrocyte-like cells such as those found within the NP of the disc, offer a potential source of cells. We have used transfection with adenoviral SOX-9, a transcription factor involved in differentiation of MSCs along the chondrogenic lineage, combined with culture in a specialised medium, to differentiate monolayer MSCs to NP-like (chondrocyte-like) cells, as shown by real-time quantitative polymerase chain reaction for NP-marker genes. We have also replicated these findings on porous, biodegradable three-dimensional (3D) poly-l-lactic acid scaffolds and shown expression and deposition of NP matrix markers such as type II collagen and aggrecan. We are therefore proposing pre-differentiation of human MSCs and seeding on porous, biodegradable 3D synthetic polymer scaffolds as a realistic tissue engineering strategy for regeneration of the degenerate human IVD.

[1]  Hwa-Chang Liu,et al.  Tissue engineering-based cartilage repair with allogenous chondrocytes and gelatin-chondroitin-hyaluronan tri-copolymer scaffold: a porcine model assessed at 18, 24, and 36 weeks. , 2006, Biomaterials.

[2]  P N Goodfellow,et al.  SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene , 1997, Molecular and cellular biology.

[3]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[4]  Ying Li,et al.  Transduction of passaged human articular chondrocytes with adenoviral, retroviral, and lentiviral vectors and the effects of enhanced expression of SOX9. , 2004, Tissue engineering.

[5]  J. Mochida,et al.  Nucleus Pulposus Allograft Retards Intervertebral Disc Degeneration , 2001, Clinical orthopaedics and related research.

[6]  Wan-Ju Li,et al.  Biological response of chondrocytes cultured in three-dimensional nanofibrous poly(ϵ-caprolactone) scaffolds† , 2003 .

[7]  A. Freemont,et al.  Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc , 2004, The Journal of pathology.

[8]  Andy Greenfield,et al.  The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos , 1995, Nature Genetics.

[9]  S. Waldman,et al.  Tissue Engineered Nucleus Pulposus Tissue Formed on a Porous Calcium Polyphosphate Substrate , 2004, Spine.

[10]  Robert Langer,et al.  Preparation and characterization of poly(l-lactic acid) foams , 1994 .

[11]  R. Tuan,et al.  A three-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells. , 2005, Biomaterials.

[12]  Jiang Hu,et al.  Cartilage-derived morphogenetic protein-1 promotes the differentiation of mesenchymal stem cells into chondrocytes. , 2004, Biochemical and biophysical research communications.

[13]  P. Roughley,et al.  Distinction between the extracellular matrix of the nucleus pulposus and hyaline cartilage: a requisite for tissue engineering of intervertebral disc. , 2004, European cells & materials.

[14]  T. Hering.  Regulation of chondrocyte gene expression. , 1999, Frontiers in bioscience : a journal and virtual library.

[15]  A. Silman,et al.  Predictors of early improvement in low back pain amongst consulters to general practice: the influence of pre-morbid and episode-related factors , 1999, Pain.

[16]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[17]  J. Wroblewski,et al.  Effects of IGF-I, EGF, and FGF on proteoglycans synthesized by fractionated chondrocytes of rat rib growth plate. , 1988, Experimental cell research.

[18]  T. Tsuchiya,et al.  Enhancement of chondrogenic differentiation of human articular chondrocytes by biodegradable polymers. , 2001, Tissue engineering.

[19]  S. F. El-Amina,et al.  Extracellular matrix production by human osteoblasts cultured on biodegradable polymers applicable for tissue engineering , 2002 .

[20]  V. Lefebvre,et al.  Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis , 1997, Developmental dynamics : an official publication of the American Association of Anatomists.

[21]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[22]  Mauro Alini,et al.  The use of biodegradable polyurethane scaffolds for cartilage tissue engineering: potential and limitations. , 2003, Biomaterials.

[23]  Su‐Li Cheng,et al.  Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. , 1994, Endocrinology.

[24]  D. Eyre,et al.  Quantitative analysis of types I and II collagens in human intervertebral discs at various ages. , 1977, Biochimica et biophysica acta.

[25]  M. E. Adams,et al.  Degeneration and the chemical composition of the human lumbar intervertebral disc , 1987, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[26]  C T Laurencin,et al.  Extracellular matrix production by human osteoblasts cultured on biodegradable polymers applicable for tissue engineering. , 2003, Biomaterials.

[27]  J F Orr,et al.  Degradation of poly-L-lactide. Part 1: in vitro and in vivo physiological temperature degradation , 2004, Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine.

[28]  A. Nachemson,et al.  Factors involved in the nutrition of the human lumbar intervertebral disc: cellularity and diffusion of glucose in vitro. , 1975, Journal of anatomy.

[29]  R Langer,et al.  Laminated three-dimensional biodegradable foams for use in tissue engineering. , 1993, Biomaterials.

[30]  Charles A Vacanti,et al.  Tissue-Engineered Composites of Anulus Fibrosus and Nucleus Pulposus for Intervertebral Disc Replacement , 2004, Spine.

[31]  D J Mooney,et al.  Development of biocompatible synthetic extracellular matrices for tissue engineering. , 1998, Trends in biotechnology.

[32]  G. Naughton,et al.  Evaluation of matrix scaffolds for tissue engineering of articular cartilage grafts. , 1997, Journal of biomedical materials research.

[33]  W. Hutton,et al.  BMP-2 and CDMP-2: stimulation of chondrocyte production of proteoglycan , 2003, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[34]  Ying Li,et al.  Retroviral transduction with SOX9 enhances re-expression of the chondrocyte phenotype in passaged osteoarthritic human articular chondrocytes. , 2005, Osteoarthritis and cartilage.

[35]  R Langer,et al.  Development of biomechanical properties and morphogenesis of in vitro tissue engineered cartilage. , 1995, Journal of biomedical materials research.

[36]  R. Soames,et al.  Human intervertebral disc: Structure and function , 1988, The Anatomical record.

[37]  A. Ratcliffe,et al.  Human articular chondrocyte adhesion and proliferation on synthetic biodegradable polymer films. , 1999, Biomaterials.

[38]  R. Tuan,et al.  Biological response of chondrocytes cultured in three-dimensional nanofibrous poly(epsilon-caprolactone) scaffolds. , 2003, Journal of biomedical materials research. Part A.

[39]  Wai-Hee Lo,et al.  Chondrogenesis of human mesenchymal stem cells encapsulated in alginate beads. , 2003, Journal of biomedical materials research. Part A.

[40]  A. Freemont,et al.  Mast cells in the pathogenesis of chronic back pain: a hypothesis , 2002, The Journal of pathology.

[41]  M. Jayson,et al.  Nerve ingrowth into diseased intervertebral disc in chronic back pain , 1997, The Lancet.

[42]  I. Martin,et al.  Quantitative analysis of gene expression in human articular cartilage from normal and osteoarthritic joints. , 2001, Osteoarthritis and cartilage.

[43]  Miya Ishihara,et al.  Tissue engineering of articular cartilage using an allograft of cultured chondrocytes in a membrane-sealed atelocollagen honeycomb-shaped scaffold (ACHMS scaffold). , 2005, Journal of biomedical materials research. Part B, Applied biomaterials.

[44]  A. Freemont,et al.  The role of interleukin-1 in the pathogenesis of human Intervertebral disc degeneration , 2005, Arthritis research & therapy.

[45]  R Cancedda,et al.  Chondrocyte differentiation. , 1995, International review of cytology.

[46]  N. Zini,et al.  Cellular and molecular events during chondrogenesis of human mesenchymal stromal cells grown in a three-dimensional hyaluronan based scaffold. , 2005, Biomaterials.

[47]  R. Tuan,et al.  In vivo response of polylactic acid-alginate scaffolds and bone marrow-derived cells for cartilage tissue engineering. , 2005, Tissue engineering.

[48]  Wei Liu,et al.  Tissue engineering of cartilage with the use of chitosan-gelatin complex scaffolds. , 2004, Journal of biomedical materials research. Part B, Applied biomaterials.

[49]  R. Tuan,et al.  Chondrogenic differentiation and functional maturation of bovine mesenchymal stem cells in long-term agarose culture. , 2006, Osteoarthritis and cartilage.

[50]  A. Freemont,et al.  Current understanding of cellular and molecular events in intervertebral disc degeneration: implications for therapy , 2002, The Journal of pathology.

[51]  A. Freemont,et al.  Expression of chondrocyte markers by cells of normal and degenerate intervertebral discs , 2002, Molecular pathology : MP.

[52]  M J Yaszemski,et al.  Polymer concepts in tissue engineering. , 1998, Journal of biomedical materials research.